Neuroprotective effects examined in Parkinsons-like, Alzheimers-like, and neurotoxic exposure models
Johns Wort and Medications St
All clinical context comes from compound-level research
One of the most commonly studied weight-loss drugs, GLP-1RAs, were initially developed to treat T2D by reducing postprandial glucose excursions, augmenting glucose-dependent insulin release, inhibiting glucagon secretion and delaying gastric emptying (136, 137)
The differential outcomes observed in Figure 3 suggest that the anxiolytic efficacy of the treatments hinges on their specific molecular configurations and the mechanisms by which they modulate neurobiological pathways
Potential Cardiovascular Support: Arginine may enhance blood flow to injured tissues, theoretically aiding nutrient delivery and accelerating recovery